Literatuur en richtlijnen

Literatuur

1. Primrose JN et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. The Lancet Oncology. 2019; 20(5): 663-73
2. Valle J et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. The New England journal of medicine. 2010; 362(14): 1273-81
3. Lamarca A et al. Advanced Biliary Cancer Working Group. Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC 06): a phase 3, open-label, randomised, controlled trial. The Lancet Oncology 2021; 22(5): 690-701

Commissie BOM adviezen

Ga naar de commissie BOM adviezen over cholangiocarcinoom.

Ga naar de commissie BOM adviezen over galblaascarcinoom. 

Richtlijnen

Ga naar de richtlijn Galweg- en galblaascarcinoom in de FMS richtlijnen­database.